De Maio, Flavio
 Distribuzione geografica
Continente #
NA - Nord America 3.426
EU - Europa 3.317
AS - Asia 2.415
SA - Sud America 588
AF - Africa 82
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.842
Nazione #
US - Stati Uniti d'America 3.299
SG - Singapore 1.203
IT - Italia 798
DE - Germania 730
CN - Cina 577
BR - Brasile 495
SE - Svezia 440
PL - Polonia 309
FR - Francia 271
FI - Finlandia 144
GB - Regno Unito 136
IE - Irlanda 129
VN - Vietnam 122
IN - India 91
ID - Indonesia 89
CA - Canada 64
AT - Austria 61
RU - Federazione Russa 57
UA - Ucraina 57
TR - Turchia 47
MX - Messico 45
HK - Hong Kong 43
AR - Argentina 41
BD - Bangladesh 35
JP - Giappone 34
NL - Olanda 32
IQ - Iraq 31
CH - Svizzera 29
KR - Corea 29
ES - Italia 28
ZA - Sudafrica 28
TW - Taiwan 25
MA - Marocco 24
IR - Iran 21
BE - Belgio 20
CZ - Repubblica Ceca 17
GR - Grecia 14
EC - Ecuador 13
LT - Lituania 11
VE - Venezuela 11
IL - Israele 10
CI - Costa d'Avorio 9
CL - Cile 9
PK - Pakistan 9
UZ - Uzbekistan 8
KE - Kenya 7
SA - Arabia Saudita 7
AU - Australia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
DO - Repubblica Dominicana 5
EG - Egitto 5
HU - Ungheria 5
PE - Perù 5
PH - Filippine 5
TN - Tunisia 5
RO - Romania 4
RS - Serbia 4
AZ - Azerbaigian 3
DK - Danimarca 3
EE - Estonia 3
HN - Honduras 3
JO - Giordania 3
KG - Kirghizistan 3
PA - Panama 3
PY - Paraguay 3
VA - Santa Sede (Città del Vaticano) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
CR - Costa Rica 2
EU - Europa 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 9.839
Città #
Singapore 584
Chandler 468
Ashburn 375
Warsaw 212
Munich 157
Rome 157
New York 155
Chicago 145
Beijing 128
Dublin 127
Los Angeles 102
The Dalles 100
Hefei 86
Kraków 84
Milan 84
Helsinki 83
Jakarta 76
Ann Arbor 69
Fairfield 62
Wilmington 62
Cattolica 60
Dallas 56
San Mateo 55
Frankfurt am Main 54
São Paulo 50
Houston 48
Boardman 47
Seattle 46
Marseille 45
North Bergen 45
Woodbridge 45
Boston 43
Vienna 43
Hong Kong 42
Jacksonville 42
Nanjing 42
Princeton 40
Moscow 36
Ho Chi Minh City 35
Tokyo 33
Nürnberg 31
Nuremberg 30
Kent 29
Seoul 28
Appignano 27
Lappeenranta 26
Cambridge 25
Denver 25
Guangzhou 25
London 25
Brooklyn 24
Buffalo 24
Atlanta 22
Dearborn 22
Montreal 22
Redwood City 22
Bremen 21
Chennai 21
Hanoi 21
Zurich 19
Brussels 18
Phoenix 18
Santa Clara 18
Rio de Janeiro 17
Andover 16
Dong Ket 16
Düsseldorf 16
Orem 16
Stockholm 16
Falls Church 15
Izmir 15
Johannesburg 14
Mexico City 14
Paris 14
Turku 14
Ankara 13
Lauterbourg 13
Salt Lake City 13
Toronto 13
Washington 13
Brno 12
Iesi 12
Lawrence 12
Macerata 12
San Francisco 12
Tianjin 12
Amsterdam 11
Augusta 11
Bexley 11
Falkenstein 11
Senigallia 11
Belo Horizonte 10
Poplar 10
Porto Alegre 10
Pune 10
Abidjan 9
Brasília 9
Kish 9
Lancaster 9
Manchester 9
Totale 5.226
Nome #
ESISTE UNA CORRELAZIONE TRA ENERGIA, QUALITÀ DELL'ARIA INDOOR E COMFORT? L’ESPERIENZA DEL PROGETTO INTERNAZIONALE SEARCH II 338
PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2 330
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 275
Unraveling the Gut Microbiome–Diet Connection: Exploring the Impact of Digital Precision and Personalized Nutrition on Microbiota Composition and Host Physiology 253
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 232
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 231
Comparative Evaluation of BD Phoenix and Vitek 2 Systems for Species Identification of Common and Uncommon Pathogenic Yeasts 229
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 184
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. 182
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis 172
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 167
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 163
Impact of pe_pgrs33 gene polymorphisms on mycobacterium tuberculosis infection and pathogenesis 159
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 153
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis 148
Multicenter Evaluation of Anyplex Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-Resistant Isolates in Pulmonary and Extrapulmonary Specimens 146
Structural determinants driving the binding process between PDZ domain of wild type human PALS1 protein and SLiM sequences of SARS-CoV E proteins 146
Direct MALDI-TOF MS Testing from Positive Blood Cultures for Rapid Identification of Bloodstream Infection-Causing Anaerobic Bacteria 141
Immunopathology of SARS-CoV-2 Infection: A Focus on T Regulatory and B Cell Responses in Children Compared with Adults 139
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 139
PE-PGRS33 contributes to Mycobacterium tuberculosis entry in macrophages through interaction with TLR2 136
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 136
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 135
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss 129
Laser-Mediated antibacterial effects of Few- and Multi-Layer Ti3C2Tx MXenes 124
Impact of protein domains on PE_PGRS30 polar localization in Mycobacteria 120
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis infection in Children 119
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients 119
Epidemiology of group A streptococcal infection: are we ready for a new scenario? 117
Simplified Testing Method for Direct Detection of Carbapenemase-Producing Organisms from Positive Blood Cultures Using the NG-Test Carba 5 Assay 115
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 115
Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay 114
Vacuum-assisted closure (VAC®) systems and microbiological isolation of infected wounds 112
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy 112
Graphene–Curcumin Coatings Resistant to SARS-CoV-2 and Mycobacteria for the Production of Personal Protective Equipment 111
Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children 109
Pilot study on cultural and metagenomic analysis of bile and biliary stents lead to unveiling the key players in stent occlusion 107
Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay 107
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 106
The Relationship Between Maternal and Neonatal Microbiota in Spontaneous Preterm Birth: A Pilot Study 105
Microbial signature of plaque and gut in acute coronary syndrome 104
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 103
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children 102
PDZ2-conjugated-PLGA nanoparticles are tiny heroes in the battle against SARS-CoV-2 97
Graphene oxide-linezolid combination as potential new anti-tuberculosis treatment 97
Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay Evolution 95
Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites 95
Comparative Fecal Microbiota Analysis of Infants With Acute Bronchiolitis Caused or Not Caused by Respiratory Syncytial Virus 94
International consensus statement on microbiome testing in clinical practice 93
First case of bacteremic liver abscess caused by an ST260-related (ST1861), hypervirulent Klebsiella pneumoniae 93
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 93
Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study 93
Characterization of Metallo β-Lactamase Producing Enterobacterales Isolates with Susceptibility to the Aztreonam/Avibactam Combination 92
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay 92
Rapid and safe one-step extraction method for the identification of Brucella strains at genus and species level by MALDI-TOF mass spectrometry 92
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 91
Graphene nanoplatelet and graphene oxide functionalization of face mask materials inhibits infectivity of trapped SARS-CoV-2 91
Unraveling the Gut Microbiota: Implications for Precision Nutrition and Personalized Medicine 89
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 88
Evaluation of PE_PGRS33 as a potential surface target for humoral responses against Mycobacterium tuberculosis 88
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin 84
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 83
Reemergence of Streptococcus pyogenes Infections in a Large Italian Hospital: A déjà vu from past Years 81
Optimized Use of the MALDI BioTyper System and the FilmArray BCID Panel for Direct Identification of Microbial Pathogens from Positive Blood Cultures 81
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 80
Profiling the Urobiota in a Pediatric Population with Neurogenic Bladder Secondary to Spinal Dysraphism 80
Enhanced chemotherapy for glioblastoma multiforme mediated by functionalized graphene quantum dots 80
Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection 79
Immune characterization of the HBHA-specific response in mycobacterium tuberculosis-infected patients with or without HIV infection 78
In situ N-acetylcysteine release from polyvinyl alcohol film for moisture-activated food packaging 76
Increasing Detection of Legionnaires’ Disease in a Large Italian Hospital in the Period 2016–2023 76
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples 76
Original Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross -protection against COVID-19 75
Profiling the gut microbiota to assess infection risk in Klebsiella pneumoniae-colonized patients 75
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 73
First bloodstream infection caused by Prevotella copri in a heart failure elderly patient with Prevotella-dominated gut microbiota: a case report 70
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients 69
Structural Basis of PE_PGRS Polymorphism, a Tool for Functional Modulation 67
The Mycobacterial HBHA Protein: a Promising Biomarker for Tuberculosis 67
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study 66
PE_PGRS proteins of Mycobacterium tuberculosis: A specialized molecular task force at the forefront of host–pathogen interaction 65
Profiling the Gastrointestinal Microbiota 61
Verification of the Vitek Reveal System for Direct Antimicrobial Susceptibility Testing in Gram-Negative Positive Blood Cultures 61
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 49
Face masks and nanotechnology: Keep the blue side up 43
Short-term gut microbiota's shift after laparoscopic Roux-en-Y vs one anastomosis gastric bypass: results of a multicenter randomized control trial 26
Totale 9.978
Categoria #
all - tutte 41.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021274 0 0 0 0 0 30 39 13 54 41 52 45
2021/2022609 36 23 29 45 21 28 18 92 38 46 118 115
2022/20231.486 200 180 91 201 82 163 69 98 145 121 94 42
2023/2024998 50 184 31 57 51 158 89 29 23 61 115 150
2024/20252.305 95 53 128 107 136 110 139 119 346 247 447 378
2025/20262.827 691 155 324 689 910 58 0 0 0 0 0 0
Totale 9.978